Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
<h4>Background</h4>Circulating epithelial tumor cell (CETC) analysis is a promising diagnostic field for estimating the risk for metastatic relapse and progression in patients with malignant disease. CETCs characterization can be used as a liquid biopsy for prognostic and predictive purp...
Guardado en:
Autores principales: | Monika Pizon, Dorothea Sonja Zimon, Ulrich Pachmann, Katharina Pachmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b34fd3cff9c749819feee132af9668a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
por: Tania Durré, et al.
Publicado: (2018) -
Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.
por: Jian-Wei Xu, et al.
Publicado: (2014) -
Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2
por: Jiayu Li, et al.
Publicado: (2021) -
Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth
por: Takefumi Uemura, et al.
Publicado: (2021) -
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.
por: Zheng Liang, et al.
Publicado: (2014)